Holistic approaches to your in vivo stroke studies.

According to the American Heart Association (AHA), stroke is the 5th leading cause of death in the USA, and every 4 out of 5 strokes are ischemic in nature: they are caused by a thrombus or embolus clogging one of the major cerebral arteries, or their branches.

The complex pathophysiologic nature of ischemic strokes makes it challenging to only use a single animal model that encompases all the different facets of the disease. At PharmaLegacy, our Intracerebral Hemorrhage model and our Ischemia-reperfusion Stroke Induced by MCAO model provide your preclinical studies with a more holistic approach on the disease. Need to know more? Contact us and let one of your experts give you all the answers you need.

Contact Us


Seamless pipelines:

  • Scientific staff with an average of over 15 years of experience in pharmacology
  • Operations and IT structured for maximum protection of clients’ data and IP
  • Capacity to run 200+ concurrent animal studies.
  • AAALAC accredited vivarium

Choose quality above all. Choose PharmaLegacy.

Contact Us

We’re ready when you are.

Tell us your pharmacology challenges.